Hepatology International

, Volume 7, Issue 2, pp 645–654 | Cite as

Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma

  • Yun-Hsuan Lee
  • Chia-Yang Hsu
  • Cheng-Yuan Hsia
  • Yi-Hsiang Huang
  • Chien-Wei Su
  • Yi-You Chiou
  • Han-Chieh Lin
  • Teh-Ia Huo
  • Shou-Dong Lee
Original Article

Abstract

Background/Aims

Chronic hepatitis B and hepatitis C virus (HBV, HCV) infection and alcoholism are common etiologies for hepatocellular carcinoma (HCC). The characteristics and impact of alcoholism and/or HCV/HBV infection on HBV- and HCV-related HCC, respectively, are investigated in this study.

Methods

A total of 1,888 patients were retrospectively investigated and categorized into six groups, HBV only (n = 977), HBV with alcoholism (n = 197), HCV only (n = 544), HCV with alcoholism (n = 67), dual HBV and HCV (n = 82), and dual virus with alcoholism (n = 21), to examine their interactions on the outcome.

Results

Compared to their counterparts, alcoholic patients coinfected with HBV and/or HCV tended to be younger, had higher male-to-female ratios, worse performance status, more severe liver cirrhosis, advanced cancer staging, and tumor burden than patients without alcoholism. In survival analysis, patients with HBV with alcoholism had a significantly decreased survival than the HBV-only group (p = 0.001). A shortened survival was also observed in HCV with alcoholism group compared to the HCV-only group (p = 0.011). Dual virus infection with alcoholism did not significantly worsen the survival compared to the dual virus infection group. In the Cox proportional hazards model, HBV with alcoholism group [risk ratio (RR) 1.299, p = 0.032] and HCV with alcoholism (RR 1.523, p = 0.025) group were independent predictors associated with decreased survival compared to their counterpart of HBV- and HCV-only groups.

Conclusions

Alcoholism in patients with HBV or HCV infection is characterized by early development of HCC with advanced cirrhosis and cancer staging at diagnosis. Alcoholism independently predicts an increased risk of mortality in patients with HBV- and HCV-related HCC.

Keywords

Alcoholism Dual virus infection HBV HCV Hepatocellular carcinoma 

Abbreviations

AFP

α-Fetoprotein

Anti-HCV

Antibody against HCV

BCLC

Barcelona Clinic Liver Cancer

CLIP

Cancer of the Liver Italian Program

CT

Computed tomography

CTP

Child–Turcotte–Pugh

ECOG

Eastern Cooperative Oncology Group

HBsAg

Hepatitis B surface antigen

HBV

Hepatitis B virus

HCC

Hepatocellular carcinoma

HCV

Hepatitis C virus

INR

International normalized ratio

MELD

Model for end-stage liver disease

MRI

Magnetic resonance imaging

TACE

Transarterial chemoembolization

TTV

Total tumor volume

References

  1. 1.
    Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004;127:S5–S16PubMedCrossRefGoogle Scholar
  2. 2.
    El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745–750PubMedCrossRefGoogle Scholar
  3. 3.
    Gelatti U, Donato F, Tagger A, et al. Etiology of hepatocellular carcinoma influences clinical and pathologic features but not patient survival. Am J Gastroenterol 2003;98:907–914PubMedCrossRefGoogle Scholar
  4. 4.
    Tan A, Yeh SH, Liu CJ, et al. Viral hepatocarcinogenesis: from infection to cancer. Liver Int 2008;28:175–188PubMedCrossRefGoogle Scholar
  5. 5.
    Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 2004;127:S87–S96PubMedCrossRefGoogle Scholar
  6. 6.
    Gitto S, Micco L, Conti F, et al. Alcohol and viral hepatitis: a mini-review. Dig Liver Dis 2009;41:67–70PubMedCrossRefGoogle Scholar
  7. 7.
    Gramenzi A, Caputo F, Biselli M, et al. Review article: alcoholic liver disease—pathophysiological aspects and risk factors. Aliment Pharmacol Ther 2006;24:1151–1161PubMedCrossRefGoogle Scholar
  8. 8.
    Hassan MM, Hwang LY, Hatten CJ, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002;36:1206–1213PubMedCrossRefGoogle Scholar
  9. 9.
    Yuan JM, Govindarajan S, Arakawa K, et al. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the US. Cancer 2004;101:1009–1017PubMedCrossRefGoogle Scholar
  10. 10.
    Ohnishi K, Iida S, Iwama S, et al. The effect of chronic habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma: relation to hepatitis B surface antigen carriage. Cancer 1982;49:672–677PubMedCrossRefGoogle Scholar
  11. 11.
    Kim WR, Gross JB Jr, Poterucha JJ, et al. Outcome of hospital care of liver disease associated with hepatitis C in the United States. Hepatology 2001;33:201–206PubMedCrossRefGoogle Scholar
  12. 12.
    Tsui JI, Pletcher MJ, Vittinghoff E, et al. Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems. J Hepatol 2006;44:262–266PubMedCrossRefGoogle Scholar
  13. 13.
    Harris HE, Ramsay ME, Andrews N, et al. Clinical course of hepatitis C virus during the first decade of infection: cohort study. BMJ 2002;324:450–453PubMedCrossRefGoogle Scholar
  14. 14.
    Marcellin P, Pequignot F, Delarocque-Astagneau E, et al. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol 2008;48:200–207PubMedCrossRefGoogle Scholar
  15. 15.
    Corrao G, Torchio P, Zambon A, et al. Exploring the combined action of lifetime alcohol intake and chronic hepatotropic virus infections on the risk of symptomatic liver cirrhosis. Collaborative Groups for the Study of Liver Diseases in Italy. Eur J Epidemiol 1998;14:447–456PubMedCrossRefGoogle Scholar
  16. 16.
    Yu MC, Yuan JM, Lu SC. Alcohol, cofactors and the genetics of hepatocellular carcinoma. J Gastroenterol Hepatol 2008;23(Suppl 1):S92–S97PubMedCrossRefGoogle Scholar
  17. 17.
    Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421–430PubMedCrossRefGoogle Scholar
  18. 18.
    Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208–1236PubMedCrossRefGoogle Scholar
  19. 19.
    Hsu CY, Huang YH, Hsia CY, et al. A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System. J Hepatol 2010;53:108–117PubMedCrossRefGoogle Scholar
  20. 20.
    Kikuchi LO, Paranagua-Vezozzo DC, Chagas AL, et al. Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma. J Clin Gastroenterol 2009;43:191–195PubMedCrossRefGoogle Scholar
  21. 21.
    Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91–96PubMedCrossRefGoogle Scholar
  22. 22.
    Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004;10:S115–S120PubMedCrossRefGoogle Scholar
  23. 23.
    Cillo U, Vitale A, Grigoletto F, et al. Prospective validation of the Barcelona clinic liver cancer staging system. J Hepatol 2006;44:723–731PubMedCrossRefGoogle Scholar
  24. 24.
    Grant BF, Dufour MC, Harford TC. Epidemiology of alcoholic liver disease. Semin Liver Dis 1988;8:12–25PubMedCrossRefGoogle Scholar
  25. 25.
    Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–699PubMedCrossRefGoogle Scholar
  26. 26.
    Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 2010;4:439–474PubMedCrossRefGoogle Scholar
  27. 27.
    Huo TI, Lin HC, Huang YH, et al. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Cancer 2006;107:141–148PubMedCrossRefGoogle Scholar
  28. 28.
    Huo TI, Lin HC, Wu JC, et al. Proposal of a modified Child–Turcotte–Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl 2006;12:65–71PubMedCrossRefGoogle Scholar
  29. 29.
    Wu SI, Liu SI, Fang CK, et al. Prevalence and detection of alcohol use disorders among general hospital inpatients in eastern Taiwan. Gen Hosp Psychiatry 2006;28:48–54PubMedCrossRefGoogle Scholar
  30. 30.
    Chen KT, Chen CJ, Fagot-Campagna A, et al. Tobacco, betel quid, alcohol, and illicit drug use among 13- to 35-year-olds in I-Lan, rural Taiwan: prevalence and risk factors. Am J Public Health 2001;91:1130–1134PubMedCrossRefGoogle Scholar
  31. 31.
    Liu JD, Leung KW, Wang CK, et al. Alcohol-related problems in Taiwan with particular emphasis on alcoholic liver diseases. Alcohol Clin Exp Res 1998;22:164S–169SPubMedCrossRefGoogle Scholar
  32. 32.
    Yu MW, Chang HC, Chang SC, et al. Role of reproductive factors in hepatocellular carcinoma: impact on hepatitis B- and C-related risk. Hepatology 2003;38:1393–1400PubMedGoogle Scholar
  33. 33.
    Huo TI, Huang YH, Hsia CY, et al. Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection? Liver Int 2009;29:767–773PubMedCrossRefGoogle Scholar
  34. 34.
    Tandon P, Garcia-Tsao G. Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. Liver Int 2009;29:502–510PubMedCrossRefGoogle Scholar
  35. 35.
    Carr BI, Pancoska P, Branch RA. Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study. Hepatol Int 2009;4:396–405PubMedCrossRefGoogle Scholar
  36. 36.
    Chen MF, Jeng LB, Lee WC. Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan. World J Surg 2002;26:742–747PubMedCrossRefGoogle Scholar
  37. 37.
    Liaw YF, Tsai SL, Chang JJ, et al. Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis. Gastroenterology 1994;106:1048–1053PubMedGoogle Scholar
  38. 38.
    Sheen IS, Liaw YF, Lin DY, et al. Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 1994;170:358–361PubMedCrossRefGoogle Scholar
  39. 39.
    Liaw YF, Tsai SL, Sheen IS, et al. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers. Am J Gastroenterol 1998;93:354–359PubMedCrossRefGoogle Scholar

Copyright information

© Asian Pacific Association for the Study of the Liver 2012

Authors and Affiliations

  • Yun-Hsuan Lee
    • 1
    • 4
  • Chia-Yang Hsu
    • 1
    • 4
  • Cheng-Yuan Hsia
    • 2
    • 4
  • Yi-Hsiang Huang
    • 1
    • 5
  • Chien-Wei Su
    • 1
    • 4
  • Yi-You Chiou
    • 3
    • 4
  • Han-Chieh Lin
    • 1
    • 4
  • Teh-Ia Huo
    • 1
    • 6
  • Shou-Dong Lee
    • 4
    • 7
  1. 1.Division of Gastroenterology, Department of MedicineTaipei Veterans General Hospital, National Yang-Ming University School of MedicineTaipeiTaiwan
  2. 2.Department of SurgeryTaipei Veterans General HospitalTaipeiTaiwan
  3. 3.Department of RadiologyTaipei Veterans General HospitalTaipeiTaiwan
  4. 4.Faculty of MedicineNational Yang-Ming University School of MedicineTaipeiTaiwan
  5. 5.Institute of Clinical MedicineNational Yang-Ming University School of MedicineTaipeiTaiwan
  6. 6.Institute of PharmacologyNational Yang-Ming University School of MedicineTaipeiTaiwan
  7. 7.Cheng Hsin General HospitalTaipeiTaiwan

Personalised recommendations